Nighttime Heart Rate Tracks With Cognitive Stage in New Parkinson's Sleep Study

An 84-patient overnight sleep and heart monitoring study is the first to compare normal cognition, mild impairment and dementia groups within Parkinson's disease side by side, finding a faster resting nighttime heart rate held an independent statistical link to lower test scores even after other factors were accounted for.

A cross-sectional study of 84 people with Parkinson's disease, published October 9, 2026 in Frontiers in Neurology, found that mean nocturnal heart rate remained independently and negatively associated with Montreal Cognitive Assessment (MoCA) scores after researchers adjusted for age, education and motor severity (B = -0.158, p = 0.003). Patients with Parkinson's disease dementia had a higher mean nocturnal heart rate, 65.80 beats per minute, than those with mild cognitive impairment or normal cognition. The same dementia group also reached REM sleep faster, with REM latency averaging 128.82 minutes against 200.54 minutes in the normal-cognition group (p = 0.006), and shorter REM latency was independently linked to higher MoCA scores in the same statistical model.

The study, run at China-Japan Friendship Hospital in Beijing, recruited patients across 2024 and split them into three groups by cognitive status: 27 with normal cognition, 27 with mild cognitive impairment, and 30 with dementia. Every participant underwent a single night of video polysomnography combined with electrocardiogram recording, letting the researchers measure sleep stages and heart rate from the same night of data rather than relying on separate visits or devices. The authors describe this as the first time the same overnight protocol has been staged across all three cognitive tiers of Parkinson's disease in one cohort.

The finding builds on smaller studies that this section has previously covered, including a 36-patient comparison of Parkinson's patients against healthy controls published in July 2026, which linked stronger parasympathetic influence on nighttime heart rhythm to better cognitive performance but did not include a dementia group. The new study's authors are explicit that their results do not explain why the heart rate link exists: they write that the cross-sectional design and the absence of direct autonomic or cholinergic nerve measurements rule out any causal or mechanistic conclusion, and that the physiological meaning of the heart rate and REM timing changes remains uncertain.

The researchers frame the practical appeal of their findings narrowly: both nocturnal heart rate and REM latency can be read off a standard overnight sleep study already used in Parkinson's care, without added equipment. Whether either measure adds anything clinically useful alongside existing cognitive and motor assessments, the authors say, is a question for future longitudinal research, not this one-night snapshot.